93 related articles for article (PubMed ID: 21443092)
1. Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence.
Yalcin S; Kilickap S; Portakal O; Arslan C; Hascelik G; Kutluk T
Hepatogastroenterology; 2010; 57(104):1395-8. PubMed ID: 21443092
[TBL] [Abstract][Full Text] [Related]
2. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.
Gervasoni A; Sandri MT; Nascimbeni R; Zorzino L; Cassatella MC; Baglioni L; Panigara S; Gervasi M; Di Lorenzo D; Parolini O
Oncol Rep; 2011 Jun; 25(6):1669-703. PubMed ID: 21455578
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
[TBL] [Abstract][Full Text] [Related]
5. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases.
Rahbari NN; Reissfelder C; Mühlbayer M; Weidmann K; Kahlert C; Büchler MW; Weitz J; Koch M
Ann Surg Oncol; 2011 Aug; 18(8):2182-91. PubMed ID: 21598056
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells in solid tumor in metastatic and localized stages.
Maestro LM; Sastre J; Rafael SB; Veganzones SB; Vidaurreta M; Martín M; Olivier C; DE La Orden VB; Garcia-Saenz JA; Alfonso R; Arroyo M; Diaz-Rubio E
Anticancer Res; 2009 Nov; 29(11):4839-43. PubMed ID: 20032444
[TBL] [Abstract][Full Text] [Related]
7. Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer.
Nakamura S; Yagata H; Ohno S; Yamaguchi H; Iwata H; Tsunoda N; Ito Y; Tokudome N; Toi M; Kuroi K; Suzuki E
Breast Cancer; 2010 Jul; 17(3):199-204. PubMed ID: 19649686
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers.
Hiraiwa K; Takeuchi H; Hasegawa H; Saikawa Y; Suda K; Ando T; Kumagai K; Irino T; Yoshikawa T; Matsuda S; Kitajima M; Kitagawa Y
Ann Surg Oncol; 2008 Nov; 15(11):3092-100. PubMed ID: 18766405
[TBL] [Abstract][Full Text] [Related]
10. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
11. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer.
Botteri E; Sandri MT; Bagnardi V; Munzone E; Zorzino L; Rotmensz N; Casadio C; Cassatella MC; Esposito A; Curigliano G; Salvatici M; Verri E; Adamoli L; Goldhirsch A; Nolè F
Breast Cancer Res Treat; 2010 Jul; 122(1):211-7. PubMed ID: 19967556
[TBL] [Abstract][Full Text] [Related]
12. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
[TBL] [Abstract][Full Text] [Related]
13. Compartmental differences of circulating tumor cells in colorectal cancer.
Rahbari NN; Bork U; Kircher A; Nimitz T; Schölch S; Kahlert C; Schmidt T; Steinert G; Ulrich AB; Reissfelder C; Büchler MW; Koch M; Weitz J
Ann Surg Oncol; 2012 Jul; 19(7):2195-202. PubMed ID: 22230943
[TBL] [Abstract][Full Text] [Related]
14. Unique localization of circulating tumor cells in patients with hepatic metastases.
Jiao LR; Apostolopoulos C; Jacob J; Szydlo R; Johnson N; Tsim N; Habib NA; Coombes RC; Stebbing J
J Clin Oncol; 2009 Dec; 27(36):6160-5. PubMed ID: 19884529
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
[TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.
Nichols AC; Lowes LE; Szeto CC; Basmaji J; Dhaliwal S; Chapeskie C; Todorovic B; Read N; Venkatesan V; Hammond A; Palma DA; Winquist E; Ernst S; Fung K; Franklin JH; Yoo J; Koropatnick J; Mymryk JS; Barrett JW; Allan AL
Head Neck; 2012 Oct; 34(10):1440-4. PubMed ID: 22076949
[TBL] [Abstract][Full Text] [Related]
18. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
Balic M; Dandachi N; Hofmann G; Samonigg H; Loibner H; Obwaller A; van der Kooi A; Tibbe AG; Doyle GV; Terstappen LW; Bauernhofer T
Cytometry B Clin Cytom; 2005 Nov; 68(1):25-30. PubMed ID: 16142788
[TBL] [Abstract][Full Text] [Related]
20. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection.
Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY
Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
